pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-147a |
Genomic Coordinates | chr9: 120244979 - 120245050 |
Description | Homo sapiens miR-147a stem-loop |
Comment | Lagos-Quintana et al. cloned miR-147 from mouse spleen tissue (supplementary information) and represented here. The expression of miR-147 has not been verified in human. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-147a | ||||||||||||||||||||||||
Sequence | 47| GUGUGUGGAAAUGCUUCUGC |66 | ||||||||||||||||||||||||
Evidence | Not_experimental | ||||||||||||||||||||||||
Experiments | |||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CREBRF | ||||||||||||||||||||
Synonyms | C5orf41, LRF | ||||||||||||||||||||
Description | CREB3 regulatory factor | ||||||||||||||||||||
Transcript | NM_153607 | ||||||||||||||||||||
Other Transcripts | NM_001168394 , NM_001168393 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CREBRF | |||||||||||||||||||||
3'UTR of CREBRF (miRNA target sites are highlighted) |
>CREBRF|NM_153607|3'UTR 1 TCAGCCTCATTGGACCACTGGTCAGAAATGTCTGCGTTTTGTCACGTTATCCATTGTAAATTTTCATTCTGTTTTGCATG 81 TCAGTTAGCATTATGTAAACATTTACAATTAGGTTACATTGTTTTAAGAACTAAGTAGCATAAGTGAAGCATGATCCAAA 161 ATACTTGATTATTGCATTTTCAGAGCATAAACCATGATTAAAACTGCTACTGGCATCAGAATTGAAAATCATATGTTTAA 241 GTAAATGTTAGGTACAGATTACAAAAATCTGTTAAAGCAAAACATTTTGGAGGAGTGAAATAGTAAAATGCCAAGTATTG 321 TGGCAGATTTATGCTCTGAACCACACAAAAAAATTGAGGAAGCATTTTTTTAAACAGTCGGTTTAAATTGTTTTTAGAAT 401 TATTGCTTTTTGTTCTAATTTTCCACAACCATTAATCTCACTTGTATATGGCACACCCAGCACTTGTGCCTGTGGGCCAT 481 ATTAGATGTTCATTGTCAGAGCTCAAGATGATATATATAAATATATATATATATATATATATATACACACACACACACAA 561 ATGTCTGTGCAAGTAAGAAAAAAAAAGCATATTCTTTGTGCCTTGTATTTTGGGGAAACTCTAAAACTGGTAATATTTTG 641 TATGATGAAAACCCTAATGAGAAAAAACAAGATATATAGATGGAAAAATTATGGGGTTTAAATGTTTTTTTGTTCCAACT 721 CTTTTTCAGATTTTTTGAATGTATATAGGACTATGTTGAAATGTAGATATATGCCACAGAGTCTGTGTATTGTATAAAAA 801 ACAAAACAAAAAACAACAAAAAAAAGATGGCTCTAGAAAACTCATATTTCGGTACTTGACCGGAAGAAGACAAATACTTG 881 CACATTATTGCGATTGTTTTATTTTTTGTACCAAAGACAAATGCAACTGATATGGCAAACTGCCAGTCTAAGTAAAGTTT 961 TGCACAGCTTACATGATACTGTATGAATGTATGAAAAAAAAGGAGAAAAAAAAGAAAAAAAAAGGTCAGGGTTAGGGATC 1041 TTACTGAACTGTGAATTTTATTTCTGTTTGGGTCCAATTATCTACAGAAGGAGCATCCATACATACAAATATTATTTTGC 1121 TGTTCCTCTAGTTCGCTTCCATAGTAGATAAGTTGGTGGCCATTTAGATGTCTTTTATTTCTGCACTTATTGTAGGAAAT 1201 TTTAATATATTTCATTTTAGTAAGCTATTGATAAAATAGTTTTTGACTTTGAAAATTAAAATGTTTATTTAGCTTATTGT 1281 AGTATACTTCCACCAGACAACAAAATAGATTATTTTTATTGTATTATGTATATATATATATGTAAAGAAAGAAAAAAGCT 1361 AAAAATATCTAATTCTTTAGTTGCCACTTTTCCGATTGATGTATTATTGTGCATGTAATATTTTCAAAGATCAACACAGG 1441 CTAAAACAAAAACAATTTATAGATTTTTATATTTTTGTACAGGTATTTTCAAACTAGCTTCTTCAAACTTAACATGTGAC 1521 TTATTCTTCTATAGTTTCTAGAATTGAGAAACATTAACACATTTAGTTTTTAGGTGCTCTTTTTTGCTCATATAAAACAG 1601 CTTCATTAGTCAGTGTTTTAACTGTGTTCAAGCTTTACCTCTTGATGAGAAATTTCTTATGTCAAGGCAGCATTATAAAC 1681 CTTCCCCCACAGATTTTTCCATCCTGTCTCTCTTACTGTTTTATTCTCAAATCTTGTGCTTTGAACTCTGAAAACTGGTG 1761 GCTTAAAAACTAAAAAAAGAAAAAAAGCATATTTAGCAAGGAAAAAAATACCAAAAATTTCAGGCATAGCTGCTGGAAAA 1841 ATTATCTATTTCTCCATTACCCACTGTAGGATTTCTTTTTTAATTATACTTTGACTATAAAGTGTCAAAGTATAATTTGT 1921 TCTTTTCTTTTACTTTGTTACCCCATTTGTAAGCTATAGCATATGAAGCTATATATATAGCTTGTGAAGGTTTGATCTAG 2001 AACACCCAGTAACAAATGAACAATGTTGCTTACCTGCTTCTTTGACATCTTAAAAAAGAAATCCAAGGAGGATTGTAAGG 2081 ATTGTCTTACCACCTTAGCTGAACTGTGATGCACAAGATTTTTCTATGTGTTTGGTGGAAATGTACCTGGTTTGTACATT 2161 CACGCTAAACAGATGATAAGCTCAAGTCTGATGGTTTAATAGAATGTAAGTTCATCGTTTAAAGCTTTTCCTTTTTAGGT 2241 TGGAGAAGGCAAAACACAGGCTTGCAAGTTGGAAGTATATGAAGTCTTGACAGAGTGTGTCTGGTAAATTGAAAAGTGTT 2321 TCAAACTATGGCAGTTTTGCAATCAGGTGAAAATCACCTCATGATATTCAGCTGATAAGGTTTATAAAATTGCCCCTTTC 2401 TAGCTGCTCTGTTAGGAATTCTGGTTTTTGATACTTTTTTCCTGTCTGCAAACCAGAATTTGATTTTTTGGTCTTGCATT 2481 TCAAAAAAAAAAAGACTTTGAATCTGTTTAGTAGATTCCATATCTTTGAGTTTCAGTGTTTTATATGTACTACTTAAGTT 2561 AAATAGTTAAAAGCTTTTAAATAGTTGAGCTTTTTAATGTTGACACTTTATTTTGTACCTATTTATATATGTATGTATAT 2641 CTTAGAAAAGCACTTTGTTAAAAAAAAATTGCATTTTATATGATTCCTGCCATTTGCTGCTAAATCTGGGCTGGTCAGAA 2721 TGCTGCAGCGATACTTGATCTATATAAAAACCTGGCAGTAAAATGTAGAGTGAAAGTTAAATCCTCTTGCTGTTTTAACT 2801 TTATCATAAAGATGACATAGGCAAGCTGTGCAGCTTTACATTTTAACCAGGGGACTCTGTGGCATTTAAAACCGTCTAGA 2881 AATGGTTGTACTTTAATGCCAGTAATAATCTGCTTCCTCTATTGTCATTAAAATATATACGTTTAGTGTATCACACAAAC 2961 CAATCTTATAAGGGTAATGTAAAAACCCCAACAATTGTACATGTTCTGTTTTTGAAAATTGTGGCATGTATTTTTGGGTG 3041 AAGATCATTAGAGAAGAGTTCTCTAAAGGTTTTCTGTGTTCATACATGGTATACAGATAGCTCATAATGAAGTCCAGAAT 3121 CTTACTTTTAAGTGAAGGCATTGTGAATTCACCTCAAGTAAACCCATTGTTCCAAAGCAATTATAAACTTTGACTCTAGT 3201 ACTACTATGATTTAAAAAAAAAAAAAACCAACAAAAACCTTTTTTCCTAGTTTCAGATACACTGGATTCTTTATAGAGTT 3281 TGTCTCCATATGAAAGCATGCTGTCCAGTCGCTCTTGTTAAGATCTTGTCTGAGTTTTGAATTGGGTGCCACACTTTTCC 3361 AGTCAATATAATTGCTTGTTCTACTGTACCATGTATGATTCTTGTCCTTTCCTATATCCTTCATGACAGATTATGATGTG 3441 GCTTTATATTGTGCCTTACTTGTACATTTAAAACTAAACGTCTTCATTCCCTTCCACTTCCTACATCTTTAACTTTGACC 3521 TTTTTGGTAAGAGAATCAGAACTATTACAAAAGCATCATGAAGGATTTCAGATGGGTATGGTTTCAAATTCCCTCTCTTT 3601 ATAGTTATTTTATATTTGTATGAAAGACCAGTTTTGGATGGTCTTTGAATATAGGGGGGAAAGATTAGCAGTAATTTCAC 3681 TACATCCCTTTTCTCTGACTTTCATGCATTTCTCATACATCTTCTTTCTGATGCTTGACTTTATTTGCTTCCTAGCAATA 3761 GTCTGCATTTAAAGAAAGGTGTGTTCAATTCATCAGCTTGAAATTGACTATTTCATTTTTCCAGGATTTTTTAGGAGAAG 3841 AGTACCCATTTTGTTTTATAAAAACAGATGACAAGTCTCTTTAAAAGAAACAGAAGTACAGTACTTTTGAAATACAATGC 3921 TGTTAGTTTGGATTTCTTTTTATATATATATATAATATTCATACAATGATCTGATGTTTGCCTTCATTAATAAAGCTGTT 4001 AGTTTATTCACCAAAATGTCAAGAATGGATGTGCTTTTCTTTATTCCACACATTTAAAAAAATTTAGCTGCTAAGATTTA 4081 ATGTTATAAGAAATGAATTCAAGTTGCCTTCAGCAAGAATTAACAAAAACTTATGTTCCCTTTCTTTATATAGTTTCCTA 4161 AAATTCTGTTCAAGTATTTTCTAGTTAATTATGTAACAGAATGTTAGCATCTCTCCATATCTTGAAACTTGAATTTTGAG 4241 AATGCATTGAATTATGCTTTCAGTGTTAAAGTAAAAGGTTTCAATTATCCTTCTAGTGAAGTCTGTTGTGGAATACCATT 4321 TCCCATGGAACTGAGGCCATTTCCACAACTTTGCACAGAACTGCAGTCTTGTTCTTCCCTTGGATCATGACAAATAAGTC 4401 TCACACAGTGCCGTAATACTTGTGGATTCTTTTGTAATCTTTGTAATCTTAATAAGGGCATTATGAGAAGACGACTCCAT 4481 GTTTTTTTAATACTTCAAACACATTGGGATGTAACAATGAATGTCAACTGTAGGAATGGTGGTTTCGTTTTAAGGAATAA 4561 GCATGTTGGGGAAAGATGATGAAAATGTACTACTGAAAGTTATACACTTCCATAGGCAAATGGGATTATGTGTTGAAGCA 4641 TAGTCCTCATGCTTAATAAACTGACTGAAATCGTAGAAATTACACCTAGGAACTGAGCTAGGCCAAATTGCCATTTTTGT 4721 TTAGAGAGTTTTGGAGGTAGTAGTGAGGGGACAGAGCCTTAAAACTACTTCCAAACAGTATTTTGGAATTGAAGACTTGG 4801 TAACTAGTGAAGAACATCAAAGTTGGGTATTTCAATGTGCCAAGTTTGGGTGAACTAGGTTCGGTTTGCCTCTTTCATAA 4881 CAATGTAAACACAATGGTGTAGTTAATTAAATTCTGGGTGGATAGGAGCAGGACTGATTACTATGTCTTGCCCTTCGCCC 4961 TTTGTTTTTTTCAGAACCAAATAACAGAAATGTGTATGTGTGTACTGTATCTGCCTTTCCACCACATTTTTATGACACTG 5041 TATTCCACTGCCTGCTTTTTTACCTTCTTTCCCTAGGATTTGTCCTACAGCTTAGTATTGTGGTTGACAGCGATACTAGG 5121 GCTGACAGCACAGAAGTCACAAGAGAAGAGTGGAAGGGCAAGAATTCAAAGCATTTGTTCATACAATGTGGCAACCTCTT 5201 TTGCATAGTTGCGTAGGATCCTGTTTGTAATGCTATCATAAATATTCTGTAGTTTTTTTTTTTTCTCTCCCAACTGGAGC 5281 TATGACACTTTTTATTGGATTCAGTCTTGTCTCTTGTCTAGAAAGAACTTTATCTTGTTGACGCATGAGCTGTTTAAAAA 5361 TTATCCTATTAAATGTTGGTTAATAGTTGTGCAGTTTTTCATTTCAGATGGAAAGGCAATGCAAATTTTGCCTTTGTTTT 5441 CTGTCACCTTCCAACCCCTGAGCACTTCTAGTCAGATACAGATTCATCAGTGTATGCAACATCCTTTGTAATTTAAAATA 5521 AAAAAAGATGAAAAGAAAACGTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 153222.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714642 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000540014.1 | 3UTR | AUAUAAAUAUAUAUAUAUAUAUAUAUAUAUACACACACACACACAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
125 hsa-miR-147a Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT003810 | VEGFA | vascular endothelial growth factor A | 2 | 1 | ||||||||
MIRT005781 | ACVR1C | activin A receptor type 1C | 1 | 1 | ||||||||
MIRT054211 | MCM3 | minichromosome maintenance complex component 3 | 4 | 1 | ||||||||
MIRT054212 | NDUFA4 | NDUFA4, mitochondrial complex associated | 4 | 1 | ||||||||
MIRT054213 | PSMA3 | proteasome subunit alpha 3 | 4 | 1 | ||||||||
MIRT071781 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT077109 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 4 | ||||||||
MIRT079945 | RNF138 | ring finger protein 138 | 2 | 2 | ||||||||
MIRT104233 | DMTF1 | cyclin D binding myb like transcription factor 1 | 2 | 2 | ||||||||
MIRT123790 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT215380 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT252677 | ZNF529 | zinc finger protein 529 | 2 | 2 | ||||||||
MIRT284530 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT395624 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT437576 | CYP2S1 | cytochrome P450 family 2 subfamily S member 1 | 2 | 1 | ||||||||
MIRT452106 | IFITM1 | interferon induced transmembrane protein 1 | 2 | 2 | ||||||||
MIRT457802 | KLHL25 | kelch like family member 25 | 2 | 2 | ||||||||
MIRT464136 | VPS28 | VPS28, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT470218 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT478219 | DDX52 | DExD-box helicase 52 | 2 | 2 | ||||||||
MIRT478986 | COLGALT1 | collagen beta(1-O)galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT479778 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT484477 | SLC9A1 | solute carrier family 9 member A1 | 2 | 2 | ||||||||
MIRT484979 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 8 | ||||||||
MIRT485017 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 8 | ||||||||
MIRT485035 | TMEM189 | transmembrane protein 189 | 2 | 8 | ||||||||
MIRT485222 | PRICKLE1 | prickle planar cell polarity protein 1 | 2 | 2 | ||||||||
MIRT490144 | TERF2IP | TERF2 interacting protein | 2 | 6 | ||||||||
MIRT490352 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 4 | ||||||||
MIRT507385 | EN2 | engrailed homeobox 2 | 2 | 4 | ||||||||
MIRT509796 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511813 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT513876 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT522966 | IPO5 | importin 5 | 2 | 2 | ||||||||
MIRT523883 | EPHA5 | EPH receptor A5 | 2 | 4 | ||||||||
MIRT529236 | PORCN | porcupine O-acyltransferase | 2 | 2 | ||||||||
MIRT535336 | PFN1 | profilin 1 | 2 | 2 | ||||||||
MIRT537694 | ELOVL6 | ELOVL fatty acid elongase 6 | 2 | 2 | ||||||||
MIRT538493 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT539138 | ARHGAP35 | Rho GTPase activating protein 35 | 2 | 2 | ||||||||
MIRT541379 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT545017 | PLP1 | proteolipid protein 1 | 2 | 2 | ||||||||
MIRT547733 | KIF23 | kinesin family member 23 | 2 | 4 | ||||||||
MIRT549394 | AKIRIN1 | akirin 1 | 2 | 2 | ||||||||
MIRT550371 | MYLK3 | myosin light chain kinase 3 | 2 | 2 | ||||||||
MIRT551909 | IGLON5 | IgLON family member 5 | 2 | 2 | ||||||||
MIRT552989 | VAMP4 | vesicle associated membrane protein 4 | 2 | 4 | ||||||||
MIRT558237 | EDA2R | ectodysplasin A2 receptor | 2 | 2 | ||||||||
MIRT558919 | CBX1 | chromobox 1 | 2 | 2 | ||||||||
MIRT559197 | BLOC1S6 | biogenesis of lysosomal organelles complex 1 subunit 6 | 2 | 2 | ||||||||
MIRT559510 | ARID3B | AT-rich interaction domain 3B | 2 | 4 | ||||||||
MIRT559610 | AMER1 | APC membrane recruitment protein 1 | 2 | 2 | ||||||||
MIRT559768 | URGCP-MRPS24 | URGCP-MRPS24 readthrough | 2 | 4 | ||||||||
MIRT565855 | NHS | NHS actin remodeling regulator | 2 | 2 | ||||||||
MIRT569043 | ZNF655 | zinc finger protein 655 | 2 | 2 | ||||||||
MIRT569153 | SIGMAR1 | sigma non-opioid intracellular receptor 1 | 2 | 2 | ||||||||
MIRT569165 | DMD | dystrophin | 2 | 2 | ||||||||
MIRT569203 | CASZ1 | castor zinc finger 1 | 2 | 2 | ||||||||
MIRT569263 | BRWD3 | bromodomain and WD repeat domain containing 3 | 2 | 2 | ||||||||
MIRT569418 | DCAF8 | DDB1 and CUL4 associated factor 8 | 2 | 2 | ||||||||
MIRT569430 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT569841 | RGS5 | regulator of G protein signaling 5 | 2 | 2 | ||||||||
MIRT570231 | NCAN | neurocan | 2 | 2 | ||||||||
MIRT570518 | SHH | sonic hedgehog | 2 | 2 | ||||||||
MIRT575643 | Mitf | microphthalmia-associated transcription factor | 2 | 3 | ||||||||
MIRT576374 | Runx1t1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 2 | 2 | ||||||||
MIRT576387 | Fhl2 | four and a half LIM domains 2 | 2 | 3 | ||||||||
MIRT576412 | Pla2g16 | phospholipase A2, group XVI | 2 | 2 | ||||||||
MIRT606871 | CHST11 | carbohydrate sulfotransferase 11 | 2 | 4 | ||||||||
MIRT606922 | CDK15 | cyclin dependent kinase 15 | 2 | 2 | ||||||||
MIRT607024 | ZEB1 | zinc finger E-box binding homeobox 1 | 2 | 2 | ||||||||
MIRT607080 | MITF | melanogenesis associated transcription factor | 2 | 3 | ||||||||
MIRT607613 | TMEM130 | transmembrane protein 130 | 2 | 4 | ||||||||
MIRT607621 | VSNL1 | visinin like 1 | 2 | 2 | ||||||||
MIRT607768 | HS6ST3 | heparan sulfate 6-O-sulfotransferase 3 | 2 | 6 | ||||||||
MIRT607880 | SATB1 | SATB homeobox 1 | 2 | 2 | ||||||||
MIRT607940 | SSX2 | SSX family member 2 | 2 | 4 | ||||||||
MIRT608011 | CARNS1 | carnosine synthase 1 | 2 | 4 | ||||||||
MIRT608026 | UBLCP1 | ubiquitin like domain containing CTD phosphatase 1 | 2 | 2 | ||||||||
MIRT608060 | SSX2B | SSX family member 2B | 2 | 4 | ||||||||
MIRT608123 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT608130 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT608210 | ADAT2 | adenosine deaminase, tRNA specific 2 | 2 | 2 | ||||||||
MIRT608554 | SBK1 | SH3 domain binding kinase 1 | 2 | 6 | ||||||||
MIRT608584 | PPP2R1B | protein phosphatase 2 scaffold subunit Abeta | 2 | 4 | ||||||||
MIRT608784 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | 2 | 4 | ||||||||
MIRT608790 | CDH12 | cadherin 12 | 2 | 2 | ||||||||
MIRT608875 | CNTF | ciliary neurotrophic factor | 2 | 6 | ||||||||
MIRT608893 | ZNF860 | zinc finger protein 860 | 2 | 2 | ||||||||
MIRT608911 | NCDN | neurochondrin | 2 | 6 | ||||||||
MIRT618020 | ELFN1 | extracellular leucine rich repeat and fibronectin type III domain containing 1 | 2 | 2 | ||||||||
MIRT625225 | RPSAP58 | ribosomal protein SA pseudogene 58 | 2 | 4 | ||||||||
MIRT627332 | TTLL7 | tubulin tyrosine ligase like 7 | 2 | 2 | ||||||||
MIRT628095 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | 2 | 2 | ||||||||
MIRT628698 | ZNF548 | zinc finger protein 548 | 2 | 2 | ||||||||
MIRT629279 | UNC13A | unc-13 homolog A | 2 | 2 | ||||||||
MIRT630656 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT634981 | TNFAIP8 | TNF alpha induced protein 8 | 2 | 2 | ||||||||
MIRT641500 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT643507 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT646369 | SLC22A6 | solute carrier family 22 member 6 | 2 | 2 | ||||||||
MIRT653985 | SEMA6A | semaphorin 6A | 2 | 2 | ||||||||
MIRT660037 | C15orf61 | chromosome 15 open reading frame 61 | 2 | 2 | ||||||||
MIRT663223 | PPY | pancreatic polypeptide | 2 | 2 | ||||||||
MIRT683701 | GFRA1 | GDNF family receptor alpha 1 | 2 | 2 | ||||||||
MIRT683921 | SLC43A3 | solute carrier family 43 member 3 | 2 | 2 | ||||||||
MIRT684100 | LHFP | LHFPL tetraspan subfamily member 6 | 2 | 2 | ||||||||
MIRT684223 | FGF14 | fibroblast growth factor 14 | 2 | 2 | ||||||||
MIRT687466 | NHSL2 | NHS like 2 | 2 | 2 | ||||||||
MIRT687694 | LEPREL1 | prolyl 3-hydroxylase 2 | 1 | 1 | ||||||||
MIRT688254 | FHL2 | four and a half LIM domains 2 | 2 | 3 | ||||||||
MIRT688850 | CAMKK2 | calcium/calmodulin dependent protein kinase kinase 2 | 2 | 2 | ||||||||
MIRT693794 | RHOG | ras homolog family member G | 2 | 2 | ||||||||
MIRT701828 | MRPL37 | mitochondrial ribosomal protein L37 | 2 | 2 | ||||||||
MIRT706391 | PPID | peptidylprolyl isomerase D | 2 | 2 | ||||||||
MIRT707197 | SDK2 | sidekick cell adhesion molecule 2 | 2 | 2 | ||||||||
MIRT707387 | SLC35F6 | solute carrier family 35 member F6 | 2 | 2 | ||||||||
MIRT707508 | PPP1R16B | protein phosphatase 1 regulatory subunit 16B | 2 | 2 | ||||||||
MIRT709807 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT710360 | CREB5 | cAMP responsive element binding protein 5 | 2 | 2 | ||||||||
MIRT715490 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT719247 | MS4A1 | membrane spanning 4-domains A1 | 2 | 2 | ||||||||
MIRT733067 | CCL5 | C-C motif chemokine ligand 5 | 3 | 0 | ||||||||
MIRT736000 | BRMS1 | breast cancer metastasis suppressor 1 | 3 | 0 | ||||||||
MIRT736216 | CAPN2 | calpain 2 | 3 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|